Healthcare Equipment and Supplies
Company Overview of Roche Diagnostics Corporation
Roche Diagnostics Corporation manufactures tools that help healthcare providers in the prevention, diagnosis, and management of various diseases. The company offers assays/reagents, instruments/systems, laboratory systems and automation products, and QC/calibration products. It provides point of care testing products, such as blood glucose, anticoagulation management, blood gas and electrolyte, cholesterol, information technology, urinalysis, and infectious disease products; and molecular products, including systems, donor screening products, and automation products. The company offers its products for various disease states, such as HPV, HIV, heart failures, and diabetes, as well as for oth...
9115 Hague Road
PO Box 50457
Indianapolis, IN 46250-0457
Founded in 1987
Key Executives for Roche Diagnostics Corporation
Chief Executive Officer and President
Group Chief Executive Officer and Member of Corporate Executive Committee
Head of Roche Diabetes Care and Member of Corporate Executive Committee
Senior Vice President of U S Point of Care Diagnostics
Compensation as of Fiscal Year 2015.
Roche Diagnostics Corporation Key Developments
Roche Diagnostics Wins $2,211,466 Federal Contract
Oct 6 15
Bureau of Medicine and Surgery (Department of the Navy), Naval Medical Logistics Command, has awarded a Not to exceed $2,211,466 federal contract on Sept. 29 for Slide Stainers, Cytology/Histology to Roche Diagnostics Corporation.
Roche Diagnostics Corporation Presents at Berenberg Diagnostics Conference 2015, May-12-2015
Mar 6 15
Roche Diagnostics Corporation Presents at Berenberg Diagnostics Conference 2015, May-12-2015 . Venue: Berenberg Offices, 5th Floor, 60 Threadneedle Street, London EC2R 8HP, United Kingdom. Speakers: Birgit Masjost, IR, Roland Diggelmann, COO.
DaVita Labs Uses Roche Technology to Launch Molecular Diagnostics Testing
May 7 14
DaVita Kidney Care announced that DaVita Labs has implemented molecular diagnostic testing using technology from Roche Diagnostics. This molecular diagnostic testing will allow DaVita Labs to be the first dialysis laboratory in the country to test for Hepatitis C (HCV) virus levels in the blood (viral load) using the COBAS Ampliprep/COBAS TaqMan HCV v.2 test from Roche. This DNA-based technology will enable DaVita Kidney Care to help nephrologists manage patients with chronic HCV in conjunction with clinical and laboratory markers of infection. The test can be used to predict the probability of sustained virologic response (SVR) early during a course of antiviral therapy, and to assess a patient's response to antiviral treatment. DaVita Labs will also evaluate viral load testing for Hepatitis B, HIV and cytomegalovirus -- all of which are FDA-approved tests - on the Roche.
Similar Private Companies By Industry
Recent Private Companies Transactions